Bacterial cellulose scale

Polybion Pushes Bacterial Cellulose Towards a New Manufacturing Scale

Polybion says it has grown its largest continuous sheet of Celium to date, marking a potentially important step in the industrial development of bacterial cellulose.

The Mexican biomaterials company describes the sheet as part of a special development project for an unnamed global company. It is not, according to Polybion, an exhibition object or a speculative concept.

The company also says it believes the material is the world’s largest continuous sheet of bacterial cellulose. That claim has not been independently confirmed, and Polybion has not published the sheet’s dimensions, production time or performance data.

Nevertheless, the development highlights one of the most difficult questions facing cultivated materials: how can a promising biological material be produced at a commercially useful size without losing consistency or performance?

Why the size of a bacterial cellulose sheet matters

Producing a larger sheet is not simply a matter of increasing the dimensions of the cultivation surface.

Bacterial cellulose is formed when cellulose-producing microorganisms create a dense network of fibres during fermentation. The material’s final characteristics depend on biological and environmental conditions throughout that process.

When the cultivation area becomes larger, manufacturers must maintain sufficiently uniform conditions across the entire surface. Variations in oxygen, nutrients, temperature or microbial activity may affect the thickness, density and mechanical behaviour of different sections.

The resulting material must also survive several post-cultivation operations.

These can include harvesting, cleaning, handling, drying, colouring, coating and transformation into components suitable for a finished product. A sheet that performs well at laboratory scale may tear, shrink, curl or dry unevenly when produced in a much larger format.

Polybion identifies cultivation, handling, consistency, drying and transformation as central challenges encountered during its latest project.

From an attractive sample to a usable material

The biomaterials industry has produced many visually compelling prototypes. Far fewer materials have progressed into repeatable, high-volume manufacturing.

A prototype can demonstrate texture, appearance or basic functionality. A commercially viable material must meet a much broader set of requirements.

Customers need predictable dimensions, stable colour, consistent strength and reliable behaviour during cutting, stitching, bonding or forming. They may also need evidence concerning durability, safety, traceability and environmental performance.

Manufacturers must be able to reproduce these properties from one production batch to another.

Polybion’s large Celium sheet may therefore be more valuable as a process-development exercise than as a record-sized object. Working at a larger scale can expose production weaknesses that would remain invisible in smaller samples.

It can also help engineers determine how the material behaves when it is handled with equipment closer to that used in commercial manufacturing.

What is Celium?

Celium is Polybion’s cultivated cellulose material. The company grows it through microbial fermentation and offers it as a material platform for applications requiring different colours, finishes and performance characteristics.

Polybion currently describes Celium as a made-to-order product cultivated in batches at its facilities in Mexico. Its website lists smaller sheets for prototyping and larger minimum orders for developments requiring customised colours or material properties.

These commercial details suggest that the company has moved beyond producing isolated demonstration samples. They do not, by themselves, establish the production volume, cost competitiveness or environmental impact of the material.

Those factors would require additional operational and lifecycle data.

The wider challenge of scaling bacterial cellulose

Bacterial cellulose has several characteristics that make it attractive to material developers.

Its nanoscale fibre network can offer useful mechanical properties, high purity and a structure that can be modified during or after cultivation. Researchers are investigating its use in textiles, packaging, composites, medical products and other advanced applications.

Scaling production remains difficult, however.

A 2026 study in the Chemical Engineering Journal described a method for producing continuous bacterial-cellulose rolls for potential roll-to-roll processing. The researchers identified low production yields and limited practical applicability as continuing obstacles to wider industrial adoption.

Their proposed process focused on controlling wet-sheet thickness while preserving fibre uniformity, strength and crystallinity.

The research is not connected to Polybion’s Celium project, but it illustrates why continuous formats matter. Rolls and large sheets can be easier to integrate into established converting and manufacturing systems than small, individually cultivated pieces. bacterial cellulose scale

Size alone does not prove commercial readiness

A larger sheet is a technical milestone, but it does not automatically demonstrate that a material is ready for mass-market adoption.

Several questions remain unanswered about Polybion’s latest development:

How large is the sheet?

How long did cultivation and processing take?

Can the same dimensions and quality be reproduced consistently?

What percentage of the sheet meets the customer’s specifications?

How much energy, water and feedstock are required?

What happens to the material at the end of its useful life?

The intended application has also not been disclosed. Without knowing whether the sheet is being developed for fashion, interiors, automotive components or another market, it is difficult to assess the relevant performance requirements.

These omissions do not invalidate the achievement. They simply limit what can currently be concluded from it.

A difficult period for alternative materials

Polybion’s announcement arrives as many alternative-material companies face a more demanding commercial environment.

Developing a new biomaterial requires sustained spending on fermentation, engineering, finishing, testing and manufacturing infrastructure. Those investments may be required for years before a company can deliver material at a competitive price and dependable volume.

Emerging materials must also compete against conventional products supported by mature global supply chains and highly optimised manufacturing processes.

For that reason, strong environmental messaging and distinctive prototypes are no longer enough. Customers and investors increasingly need evidence that a material can be produced repeatedly, integrated into real products and supported by a credible commercial model.

Polybion argues that material development must continue beyond changes in funding and public attention. Its latest sheet is presented as evidence of that long-term technical effort.

Environmental claims require supporting evidence

Bacterial cellulose is frequently described as a sustainable alternative to animal-derived or fossil-based materials. Its biological origin may offer advantages, but it does not guarantee a lower overall environmental impact.

The result depends on the complete production system.

Relevant factors include the source of the fermentation feedstock, energy consumption, water use, processing chemicals, finishing treatments, transport, durability and end-of-life conditions.

A material that biodegrades under controlled laboratory conditions may not necessarily break down quickly in a landfill, home-composting system or natural environment.

Similarly, a material made with biological processes can still have a substantial footprint if cultivation and drying require large amounts of energy.

Credible comparisons therefore require transparent lifecycle assessments based on commercial production conditions.

What should happen next?

The next meaningful step for Celium may not be the production of an even larger sheet.

More important evidence would include repeat manufacturing runs, disclosed technical specifications and successful integration into the global company’s final production process.

Independent testing could also establish whether the material maintains consistent properties across its entire surface.

Data covering production yield, waste, energy use and lifecycle impact would make it possible to evaluate Celium more accurately against conventional materials and competing biomaterial platforms.

Until such information is available, Polybion’s large sheet should be viewed as a promising manufacturing milestone rather than proof of full industrial readiness.

A sign of progress, not an endpoint

Polybion’s latest Celium project shows how the discussion around bacterial cellulose is changing.

The central question is no longer only whether microorganisms can grow an appealing material. Developers must now prove that cultivated cellulose can be produced in useful formats, processed reliably and delivered with consistent properties.

The company’s record claim remains unverified, and several important details have not been released. Even so, producing a large continuous sheet for a customer-led development project suggests that the work is advancing beyond purely speculative design.

For bacterial cellulose, the real breakthrough will not be one exceptional sheet. It will be the ability to manufacture thousands of consistently performing sheets—or continuous rolls—at a cost and environmental impact that customers can justify.

Biodegradable Food Packaging Gets Stronger With Coconut-Derived Cellulose

More…